Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GLP1R | P43220 | 8/20 | 0.74 |
| ▸ | NOD1 | Q9Y239 | 9/20 | 0.57 |
| ▸ | SLC6A5 | Q9Y345 | 1/20 | 0.47 |
| ▸ | CCKAR | P32238 | 2/20 | 0.47 |
| ▸ | CCKBR | P32239 | 2/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25898671 | 1.00 | GLP1R (0.74) | GLP1RNOD1SLC6A5CCKARCCKBR | |
| SCHEMBL24311233 | 1.00 | GLP1R (0.74) | GLP1RNOD1SLC6A5CCKARCCKBR | |
| SCHEMBL24311305 | 1.00 | GLP1R (0.74) | GLP1RNOD1SLC6A5CCKARCCKBR | |
| SCHEMBL24311230 | 1.00 | GLP1R (0.74) | GLP1RNOD1SLC6A5CCKARCCKBR | |
| SCHEMBL22648041 | 0.98 | GLP1R (0.73) | GLP1RNOD1SLC6A5 | |
| SCHEMBL24311335 | 0.96 | GLP1R (0.78) | GLP1RNOD1SLC6A5 | |
| SCHEMBL20698041 | 0.95 | GLP1R (0.67) | GLP1RNOD1SLC6A5 | |
| SCHEMBL25455653 | 0.94 | GLP1R (0.77) | GLP1RNOD1SLC6A5 | |
| SCHEMBL13640851 | 0.94 | GLP1R (0.77) | GLP1RNOD1 | |
| SCHEMBL24311324 | 0.94 | GLP1R (0.83) | GLP1RNOD1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11713344-B2 | Acylated oxyntomodulin peptide analog | DONG-A ST CO., LTD. (KR) | 2023-08-01 | — | — | US | disclosed |
| US-11236142-B2 | Acylated oxyntomodulin peptide analog | DONG-A ST CO., LTD. (KR) | 2022-02-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11713344-B2 | Acylated oxyntomodulin peptide analog | GLP1R, GIPR, GPR119 | GLP1R 1/4885NOD1 386/4885SLC6A5 4071/4885 |
| US-11236142-B2 | Acylated oxyntomodulin peptide analog | GLP1R, GIPR, GPR119 | GLP1R 1/4885NOD1 536/4885SLC6A5 3936/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.